Trial Filter

BETA

An intelligent search tool for clinical trials

Back|NCT07213154RecruitingUpdated Dec 16, 2025|Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

Official Title

Assessment of Novel Label-free Optical Imaging Technology for the Evaluation of Skin Lesions

Sponsor

Emory University

Enrollment

Timeline

Oct 2025 → Sep 2027

About This Study

This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.

Eligibility Criteria

Inclusion Criteria

1Male or Female
2Candidate with skin lesions
3Signed study-specific informed consent prior to study entry
4≥ 18 years old

Exclusion Criteria

1Prior surgery or radiotherapy to the area to be treated

Locations

2 sites participating in this study

Emory University Hospital Midtown

Atlanta, Georgia 30308

Recruiting

Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia 30322

Recruiting

Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR

Data sourced from ClinicalTrials.govView on ClinicalTrials.gov →